Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
AstraZeneca shares climb after earnings beat estimates as cancer drug portfolio drives strong growth | Stock Market News
Adjusted earnings per share, excluding certain items, climbed 21% to $2.63 in the latest quarter, comfortably surpassing analysts' expectations
Ähnliche Seiten
AstraZeneca (AZN) Stock Climbs on Strong Q2 Earnings Beat Powered by Cancer Drug Sales - MoneyCheck
https://moneycheck.com/astrazeneca-azn-stock-climbs-on-strong-q2-earnings-beat-powered-by-cancer-drug-sales/
AstraZeneca (AZN) Stock Climbs After Strong Q2 Earnings Beat Analyst Expectations - Blockonomi
https://blockonomi.com/astrazeneca-azn-stock-climbs-after-strong-q2-earnings-beat-analyst-expectations/
Netflix earnings in focus as shares gain slightly amid growth concerns | Stock Market News
https://www.livemint.com/market/stock-market-news/netflix-earnings-in-focus-as-shares-gain-slightly-amid-growth-concerns-11784221999540.htmlVBL shares bounce back after mixed earnings, but can India volume growth hold up? | Stock Market News
https://www.livemint.com/market/mark-to-market/vbl-shares-varun-beverages-stock-q2-results-volume-growth-campa-cola-11785311471513.html
US Stock Market: CME shares jump 6% after Q2 profit beats estimates; strong hedging demand boosts results - The Economic Times
https://economictimes.indiatimes.com/markets/us-stocks/news/us-stock-market-cme-shares-jump-6-after-q2-profit-beats-estimates-strong-hedging-demand-boosts-results/articleshow/132571632.cms